Post-transplant lymphoproliferative disorder treated with rituximab: case report.
Meng
Hai-tao
HT
Department of Hematology, First Affiliated Hospital of Zhejiang University, Hangzhou 310003, China. menghait2004@163.com
Li
Ying
Y
Liu
Jian-hua
JH
Xu
Gai-xiang
GX
Teng
Xiao-dong
XD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab